바이오프로세스 기술 시장 보고서 : 동향, 예측, 경쟁 분석(-2030년)

Bio-Process Technology Trends and Forecast

The future of the global bio-process technology market looks promising with opportunities in the biopharmaceutical, contract manufacturing organization, and academic research institute markets. The global bio-process technology market is expected to reach an estimated $71.7 billion by 2030 with a CAGR of 12.3% from 2024 to 2030. The major drivers for this market are growing demand for next-generation bio-based products and rising prevalence of chronic diseases.

Lucintel forecasts that biologics safety testing is expected to witness the highest growth over the forecast period.

Within this market, biopharmaceutical is expected to witness the highest growth over the forecast period.

North America is expected to witness highest growth over the forecast period.

Emerging Trends in the Bio-Process Technology Market

Various trends emerge in the bio-processing technology market to characterize its future, reflecting improvements in technologies, innovations in practices of industries, demands for sustainability, and efficiency. All these call for understanding on the part of the stakeholders if they ever hope to know their way around in this evolving landscape of bio-technology processes.

• Adopting Continuous Processing: In bioprocess technology, continuous processing is gaining momentum. The process means the raw material and product flow continuously through the process to ensure gains in efficiency, cost reduction, and scalability improvement. Continuous processing allows for superior control and optimization of bioprocesses-leading to higher yields and lower production costs.
• Integrating real-time analytics: will also allow the transformation of bio-process technology. Advanced sensors and data analytics tools capable of monitoring and controlling in real time are integrated with bioprocessing systems. The trend enables finer control, faster turnarounds, and a smoother process flow that results in higher product quality and less downtime.
• Sustainability Focus: There is an increasing emphasis on the development of sustainable bio-process technologies. This not only Quickens the processes but reduces wastes, energy consumption, and environmental impacts associated with conventional methods. Besides applying new green bioprocesses and eco-friendly materials, sustainability is increasingly a driver for innovation and keeping up with regulations in the bio-process industry.
• New Advances in Cell Line Development: Innovations within cell line development are improving the production of biopharmaceuticals and other bio-products. New techniques have been developed that enhance stability, productivity, and consistency within the cell line. This is quite important for scaling up production and high-quality output in the bio-process industry.
• Growth in Personalized Medicine: The increasing trend of personalized medicine drives innovation in bio-process technology. For such therapies and treatments, individually tailored therapies call for specialized bioprocessing techniques and technologies. This will continue to drive the industry towards more flexible and adaptable bio-process systems to meet the needs of personalized medicine.

Upcoming trends in the bio-process technology market include continuous processing, real-time analytics, and sustainability. The other driving forces for innovation and change are the advances in cell line development and growth in personalized medicine. These are coupled with efficiency, scalability, and environmental responsibility improvements; hence, promising a different future for bio-process technology.

Recent Developments in the Bio-Process Technology Market

Recent developments in the bio-process technology market demonstrate several key advances transforming industry segments. The developments epitomize increasing efficiency, scalability, and sustainability through innovative technologies and the evolution of market demand.

• Continuous Bioprocessing Implementation: Continuous bioprocessing technologies are increasingly gaining acceptance for bringing efficiencies and reducing costs. The technique allows for the continuous running of bioprocesses, thus offering greater process control with higher yields and faster production times than the conventional batch processing.
• Single-Use Technologies Development: Among the fastest-growing areas, the application of single-use technologies in bioprocessing is starting to prevail. The main advantages of applying single-use bioreactors and filtration systems include flexibility, low contamination risks, and overall cost decrease. Such techniques have been found useful in small-scale productions and rapid development cycles.
• Advanced PAT systems: are now integrated into bioprocessing systems to enhance process monitoring and control. Advanced sensors and analytical tools are providing real-time data on critical process parameters, thus driving better process optimization, quality control, and quicker problem resolution.
• Green Bioprocess Development: There is clear emphasis on the development of green bioprocesses that have limited environmental impact. Various innovations reported involve energy-efficient bioreactors, strategies relating to waste reduction, and renewable feedstocks. Such developments put into practice global sustainability goals and regulatory imperatives.
• Expanding Biopharmaceutical Manufacturing Capacity: There is an increasing trend towards the expansion of capacity in the manufacturing of biopharmaceuticals due to high demands. This encompasses the expansion in production facilities to achieve scale-up, process optimization, and enhancement of efficiency in manufacturing biopharmaceuticals through sophisticated technologies and automation.

Recent development within the bio-process technology market includes continuous bioprocessing, single-use technologies, and green bioprocess. The dynamics, because of this, have ever since been driving significant alteration in the industry. Advancements are improving efficiency, scalability, and environmental sustainability that reshape the CMO landscape by setting new standards for bio-process technology.

Strategic Growth Opportunities for Bio-Process Technology Market

This can be observed in the wide range of applications that the development of opportunities in bio-process technology growth has, mainly because of technological advances, increasing demand for biopharmaceuticals, and the drive toward sustainable solutions. Identification of these opportunities will be important for stakeholders, which are willing to capitalize on market trends for growth.

• Biopharmaceutical Manufacturing: Interest in and demand for biopharmaceuticals create growth opportunities in bioprocessing technology. Continuous processing and single-use technologies make production techniques better and allow companies to increase scalability with demands for therapeutic proteins and vaccines.
• Agricultural Biotechnology: Large potential is existing in the development of bio-based pesticides, bio-based fertilizers, and many others. Innovation in bio-process technology further enhances production levels for these sustainable products. These are sustainable solutions to chemical-based products that help in maintaining environmentally friendly agricultural practices.
• Environmental Bioremediation: Interest in the application of bio-process technology to environmental bioremediation is on the increase. More sophisticated and efficient technologies involved in the use of microorganisms for cleaning up pollutants and waste are arising. It therefore presents another opportunity avenue for companies to solve environmental problems and contribute toward a broader solution of sustainability issues.
• Bio-based Chemicals and Materials: The development of bio-based chemicals and materials is opening up a series of opportunities for growth in different industries. Bio-process technological advances are paving the way for sustainable manufacturing of alternatives to petrochemical-based products like biodegradable plastics and bio-based solvents.
• The growth in personalized medicine: opens up new avenues in which bio-process technology will develop specific therapies and treatments. Ongoing innovations at the cell line development stage and in bioprocessing techniques go on to continue support for the production of personalized medical products, hence driving growth in the sector.

Some of these strategic growth opportunities are in biopharmaceutical manufacturing, agricultural biotechnology, environmental bioremediation, chemicals derived from biology, and personalized medicine. Such strategic growth opportunities reflect the future of the bioprocess technology industry as one with sustainable and innovative solutions in high demand.

Bio-Process Technology Market Driver and Challenges

The major drivers and challenges affecting the bio-process technology market include technological, economic, and regulatory considerations. These have become significant in determining the pace of growth, rate of innovation, and level of operating efficiency within the industry. While on one hand, technological advancement propels the creation and development of processes that could be much more efficient and easily scaled up, the economic element and regulatory burdens affect markets and rates of adoption.

The factors responsible for driving the bio-process technology market include:

1. Technological Improvement: Innovation in bio-process technology, including continuous processing, improved sensors, and automation-a process that greatly helps spur market growth. These improvements enhance process efficiency, scalability, and control, improving yields and reducing production costs. Improved technologies further enable the formulation of new, more efficient bioproducts to meet demand from the rising pharmaceutical industry, among others related to environmental management.

2. Increase in Biopharmaceutical Demand: Growth factors of biopharmaceutical demand, including demographic factors such as an aging population and rising prevalence of chronic diseases, also enhance this segment as a driver in the bio-process technology market. Moreover, biopharmaceutical demand needs to be further complemented with the development of bioprocessing technologies in order to enhance the efficiency and scalability of manufacturing therapeutic proteins, vaccines, and other biologics. The quest for high-quality, cost-effective biopharmaceuticals furthers creative innovation and investment in bioprocess technologies.

3. The regulatory support for sustainability: supportive regulatory frameworks emphasizing environmental sustainability give momentum to the technologies applied in bio-processes. Regulations relating to waste reduction, energy efficiency, and renewable resource usage are the motivating factors in formulating green bioprocesses. Compliance with such regulations does not only meet the environmental standards set by organizations but also offers competitive advantages in the market due to the response against the call of global sustainability.

Challenges in the bio-process technology market are:

1. Another major constraint is the high operational cost. The big cost of equipment, raw materials, and operation presents a great challenge for bio-process technologies. This could prevent small companies from entering into such industries or scaling up new technologies. High production costs must relate to the pricing of bioproducts affecting the market competitiveness and accessibility.

2. Regulatory Compliance: It is complex and time-consuming for the bio-process technology market to manage a number of complex and tight regulatory requirements. The various regulations on biopharmaceuticals, environmental standards, and safety protocols require a great deal of resources and competencies. Ensuring that these regulations have been met is time-consuming and expensive, thus this could delay the development and marketing of a product.

3. Technical Complexity: The use of bio-process technologies requires great technical complexity for their widespread adoption. There is a need to conceptualize and then implement several advanced technologies that depend upon one's expertise and technical skill, which may not necessarily be available to every organization. The technological complexities, therefore, act as a bottleneck towards the implementation of innovative solutions, thus impacting efficiency in operations involving bio-processes.

The highly competitive market of bio-process technology is driven by increasing demand for biopharmaceuticals, driven by technological advancement; regulatory support for sustainability; the rise of personalized medicine; and economic incentives to innovators. On the other hand, high production costs, along with regulatory compliance and technological complexities, need to be overcome in order to realize the full potential of the market.

List of Bio-Process Technology Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies bio-process technology companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the bio-process technology companies profiled in this report include-

• Hoffmann-La Roche
• Sartorius
• Thermo Fisher Scientific
• Agilent
• ELITech

Bio-Process Technology by Segment

The study includes a forecast for the global bio-process technology by product type, application, end use, and region.

Bio-Process Technology Market by Product Type [Analysis by Value from 2018 to 2030]:

• Biologics Safety Testing
• Cell Culture
• Cell Expansion
• Cell Line Development
• Flow Cytometry
• Tangential Flow Filtration
• Flow Cytometry

Bio-Process Technology Market by Application [Analysis by Value from 2018 to 2030]:

• Antibiotics
• Biosimilars
• Recombinant Proteins
• Others

Bio-Process Technology Market by End Use [Analysis by Value from 2018 to 2030]:

• Biopharmaceutical Companies
• Contract Manufacturing Organizations
• Academic Research Institute
• Others

Bio-Process Technology Market by Region [Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Bio-Process Technology Market

This bio-process technology market is still subjected to serious transformation triggered by rapidly developing biotechnology, increasing demand for biopharmaceuticals, and changing regulatory environments. The developments in this field are enhancing the efficiency, scalability, and sustainability of bio-processes from industries such as pharmaceuticals, agriculture, and environmental management. Some major markets like the United States, China, Germany, India, and Japan form the hub of this transformation-they each carry some interesting advancement and strategies in their own significant way.

• United States: Automation and digitalization continue to advance in the bio-process technology market in the U.S. In general, biotechnology firms in the U.S. are increasingly using sophisticated bioprocessing platforms coupled with real-time analytics to achieve even higher efficiencies and economies in manufacturing. This includes innovative continuous processing technologies and advanced cell culture systems making the manufacturing process of biopharmaceuticals more efficient while improving the overall scalability and yield of the process.
• China: It is rapidly ramping up the capabilities of large-scale bio-process technology in China with the aim of making operations cost-effective. The latest news is about investments in biomanufacturing infrastructures and the implementation of advanced process analytical technologies-PAT. Chinese firms also partner with international companies to adopt state-of-the-art technologies in improving their bioprocessing capabilities.
• Germany: Integration of sustainable practices into bio-process technology is leading in Germany. The main evolutions have been the development of green bioprocesses to minimize the generation of waste and energy consumption. Optimizing the designs of bioreactors and using advanced fermentation technologies are also under investment in Germany, enhancing the efficiency and environmental friendliness of the processes under biotechnology.
• India: The Indian bioprocess technology market is still in development but aims to reach low-cost, scalable biopharmaceutical production. The latest technological advancements include single-use bioreactor system implementation and microbial fermentation technology improvement. Indian companies also work towards enhancing their capabilities related to biosimilars manufacturing and other high-value bioproducts, using this opportunity to fulfill the demand of domestic and international markets.
• Japan: Japan is modernizing the technology for bio-process through extensive innovation in integration of processes and automation. Few of the recent development works include the adoption of high-throughput screening technologies and the implementation of smart bioprocessing systems. Major companies in Japan are also targeting the development of bio-based chemicals and materials by using their precision biotechnology to act as the driving force behind their growth in this sector.

Features of the Global Bio-Process Technology Market

Market Size Estimates: Bio-process technology market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Bio-process technology market size by product type, application, end use, and region in terms of value ($B).

Regional Analysis: Bio-process technology market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, applications, end uses, and regions for the bio-process technology market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the bio-process technology market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

FAQ

Q1. What is the bio-process technology market size?

Answer: The global bio-process technology market is expected to reach an estimated $71.7 billion by 2030.

Q2. What is the growth forecast for bio-process technology market?

Answer: The global bio-process technology market is expected to grow with a CAGR of 12.3% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the bio-process technology market?

Answer: The major drivers for this market are growing demand for next-generation bio-based products and rising prevalence of chronic diseases.

Q4. What are the major segments for bio-process technology market?

Answer: The future of the bio-process technology market looks promising with opportunities in the biopharmaceutical, contract manufacturing organization, and academic research institute markets.

Q5. Who are the key bio-process technology market companies?

Answer: Some of the key bio-process technology companies are as follows:

• Hoffmann-La Roche
• Sartorius
• Thermo Fisher Scientific
• Agilent
• ELITech

Q6. Which bio-process technology market segment will be the largest in future?

Answer: Lucintel forecasts that biologics safety testing is expected to witness the highest growth over the forecast period.

Q7. In bio-process technology market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the bio-process technology market by product type (biologics safety testing, cell culture, cell expansion, cell line development, flow cytometry, tangential flow filtration, and flow cytometry), application (antibiotics, biosimilars, recombinant proteins, and others), end use (biopharmaceutical companies, contract manufacturing organizations, academic research institute, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
• Market Report

Table of Contents

1. Executive Summary

2. Global Bio-Process Technology Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Bio-Process Technology Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Bio-Process Technology Market by Product Type
  • 3.3.1: Biologics Safety Testing
  • 3.3.2: Cell Culture
  • 3.3.3: Cell Expansion
  • 3.3.4: Cell Line Development
  • 3.3.5: Flow Cytometry
  • 3.3.6: Tangential Flow Filtration
  • 3.3.7: Flow Cytometry
• 3.4: Global Bio-Process Technology Market by Application
  • 3.4.1: Antibiotics
  • 3.4.2: Biosimilars
  • 3.4.3: Recombinant Proteins
  • 3.4.4: Others
• 3.5: Global Bio-Process Technology Market by End Use
  • 3.5.1: Biopharmaceutical Companies
  • 3.5.2: Contract Manufacturing Organizations
  • 3.5.3: Academic Research Institute
  • 3.5.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Bio-Process Technology Market by Region
• 4.2: North American Bio-Process Technology Market
  • 4.2.1: North American Bio-Process Technology Market by Product Type: Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration, and Flow Cytometry
  • 4.2.2: North American Bio-Process Technology Market by End Use: Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute, and Others
• 4.3: European Bio-Process Technology Market
  • 4.3.1: European Bio-Process Technology Market by Product Type: Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration, and Flow Cytometry
  • 4.3.2: European Bio-Process Technology Market by End Use: Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute, and Others
• 4.4: APAC Bio-Process Technology Market
  • 4.4.1: APAC Bio-Process Technology Market by Product Type: Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration, and Flow Cytometry
  • 4.4.2: APAC Bio-Process Technology Market by End Use: Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute, and Others
• 4.5: ROW Bio-Process Technology Market
  • 4.5.1: ROW Bio-Process Technology Market by Product Type: Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration, and Flow Cytometry
  • 4.5.2: ROW Bio-Process Technology Market by End Use: Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Bio-Process Technology Market by Product Type
  • 6.1.2: Growth Opportunities for the Global Bio-Process Technology Market by Application
  • 6.1.3: Growth Opportunities for the Global Bio-Process Technology Market by End Use
  • 6.1.4: Growth Opportunities for the Global Bio-Process Technology Market by Region
• 6.2: Emerging Trends in the Global Bio-Process Technology Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Bio-Process Technology Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Bio-Process Technology Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Hoffmann-La Roche
• 7.2: Sartorius
• 7.3: Thermo Fisher Scientific
• 7.4: Agilent
• 7.5: ELITech